Parathyroid Glands
Medicine & Life Sciences
100%
Hyperparathyroidism
Medicine & Life Sciences
72%
Parathyroidectomy
Medicine & Life Sciences
69%
Adrenalectomy
Medicine & Life Sciences
63%
Kidney
Medicine & Life Sciences
45%
Inferior Vena Cava
Medicine & Life Sciences
44%
Seaweed
Medicine & Life Sciences
41%
Pheochromocytoma
Medicine & Life Sciences
37%
Higashiyama, T. ,
Sugino, K. ,
Hara, H. ,
Ito, K. I. ,
Nakashima, N. ,
Onoda, N. ,
Tori, M. ,
Katoh, H. ,
Kiyota, N. ,
Ota, I. ,
Suganuma, N. ,
Hibi, Y. ,
Nemoto, T. ,
Takahashi, S. ,
Yane, K. ,
Ioji, T. ,
Kojima, S. ,
Kaneda, H. ,
Sugitani, I. &
Tahara, M. ,
09-2022 ,
In: European Journal of Cancer. 173 ,
p. 210-218 9 p. 研究成果: Article › 査読
lenvatinib
100%
Anaplastic Thyroid Carcinoma
85%
Safety
35%
Response Evaluation Criteria in Solid Tumors
6%
Survival
5%
Uchida, H. ,
Hibi, Y. ,
Kagawa, C. ,
Ogawa, K. &
Shimizu, Y. ,
01-09-2016 ,
In: International Surgery. 101 ,
9-10 ,
p. 483-486 4 p. 研究成果: Article › 査読
Adrenalectomy
100%
Inferior Vena Cava
95%
Hemorrhage
56%
Hyperaldosteronism
13%
Hemostatics
11%
Hibi, Y. ,
Hayakawa, N. ,
Hasegawa, M. ,
Ogawa, K. ,
Shimizu, Y. ,
Shibata, M. ,
Kagawa, C. ,
Mizuno, Y. ,
Yuzawa, Y. ,
Itoh, M. &
Iwase, K. ,
02-2015 ,
In: Surgery Today. 45 ,
2 ,
p. 241-246 6 p. 研究成果: Article › 査読
Hyperaldosteronism
100%
Hyperkalemia
98%
Primary Hyperparathyroidism
94%
Adrenalectomy
90%
polystyrene sulfonic acid
66%